Wesley Pharmaceuticals
Wesley Pharmaceuticals is an Orlando-based FDA-registered 503B outsourcing facility that compounds and sells sterile injectable pharmaceuticals directly to U.S. medical practices and pharmacies for office-use administration, operating as a sister company of Olympia Pharmaceuticals.
- Company typePrivate
- Founded2025
- HeadquartersOrlando, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wesley Pharmaceuticals does
Wesley Pharmaceuticals is a privately held, FDA-registered 503B outsourcing facility founded in 2025 in Orlando, Florida as a sister company of Olympia Pharmaceuticals. The company produces compounded sterile injectable pharmaceuticals for office-use administration, supplying medical practices directly under its 503B registration — eliminating the need for individual prescriptions — and supplying pharmacies with stock to mitigate drug shortages. Wesley is currently licensed in 29 states with continued geographic expansion planned through 2026, and operates from a 55,000 sq ft facility that triples the parent's production capacity.
The company's product portfolio centers on injectable wellness and longevity formulations including NAD+ (100mg/mL, launched February 2026), Zinc Sulfate (10mg/mL, launched December 2025), Methylcobalamin B12 (5mg/mL), Glutathione (200mg/mL), Magnesium Chloride (300mg/mL), Vita Complex B-blend, and Taurine (50mg/mL) — all formulated for IV, IM, or SQ administration and featuring differentiated packaging such as flip-top caps and durable glass vials. The underlying technology platform is cGMP-compliant sterile compounding within an FDA-inspected outsourcing facility framework, with sourcing leverage from Olympia's existing product portfolio.
Wesley sells B2B to licensed healthcare providers and pharmacies on a quote-based, pay-as-you-go model through a unified ordering portal shared with Olympia Pharmaceuticals. Distribution is direct via enterprise field sales across the United States; no public pricing or revenue is disclosed. Leadership is pharmacy-led, with CEO Mark Mikhael appointed to the Florida Board of Pharmacy and recognized as Pharmacist of the Year by the Florida Society of Health-System Pharmacists, alongside CFO Joshua Fritzler and Co-founder Naomi Loomis. The company is family-owned with no venture or private equity investment disclosed to date.
Wesley Pharmaceuticals firmographics
Firmographics- Name
- Wesley Pharmaceuticals
- Legal name
- Wesley Pharmaceuticals
- Website
- https://wesleypharmaceuticals.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wesley Pharmaceuticals is an Orlando-based FDA-registered 503B outsourcing facility that compounds and sells sterile injectable pharmaceuticals directly to U.S. medical practices and pharmacies for office-use administration, operating as a sister company of Olympia Pharmaceuticals.
- Ownership category
- akta.pro rank
Wesley Pharmaceuticals industry classification
Industry- Product category
- Compounded Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
- akta.pro secondary industry
- Compounding & Customized Medication Management Support (HSABALAL)
Keywords
Where Wesley Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Orlando
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wesley Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Office-Use Pharmaceutical Sales: 503B outsourcing facility supplying medical practices with compounded prescription medications and office stock, eliminating the need for individual prescriptions. Products are sold directly to licensed healthcare providers for office administration.
- Over-the-Counter Pharmacy Stock: Supplying pharmacies with compounded medications to ensure patients are never affected by drug shortages.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B pricing for healthcare providers |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Wesley Pharmaceuticals product offering
Product offeringCore offering
Wesley Pharmaceuticals is an FDA-registered 503B outsourcing facility that manufactures and supplies cGMP-compliant sterile compounded injectable medications directly to licensed healthcare providers and pharmacies for office administration. The company produces wellness, longevity, immune support, and metabolic health injections including NAD+, Zinc Sulfate, Methylcobalamin, Glutathione, Magnesium Chloride, Vita Complex, and Taurine formulations, packaged in modernized vials with flip-top caps and durable glass construction.
Product overview
Wesley Pharmaceuticals is a Florida-based 503B outsourcing facility and sister company of Olympia Pharmaceuticals, offering compounded pharmaceutical products for office use. The product portfolio consists of injectable wellness and longevity formulations including NAD+ Injection for anti-aging and cellular health, Zinc Sulfate Injection for immune support, Methylcobalamin Injection for vitamin B12 supplementation, Glutathione Injections as an antioxidant, Magnesium Chloride for mineral deficiency, Vita Complex Injection as a B-complex blend, and Taurine Injection for amino acid support. All products are available in various concentrations for IV, IM, or SQ administration, designed for healthcare providers to stock in their practices. The company supplies prescription and over-the-counter compounded medications to medical practices across licensed states, with plans for continued geographic expansion throughout 2026.
Differentiator
Problem solved
Functional benefit
Products and services
- NAD+ Injection NAD+ (Nicotinamide Adenine Dinucleotide) injection for IV, IM, or SQ administration. A naturally occurring molecule involved in cell signaling and metabolic pathways that converts macronutrients into ATP (cellular fuel). Supports healthy brain function, stamina, cellular repair, and tissue longevity, and is also used in addiction management therapy for its effect on dopamine levels. Sold as office-use supply to licensed healthcare providers.
- Zinc Sulfate Injection Zinc Sulfate Injection at 10mg/mL concentration for IV administration. An essential mineral vital for growth and overall wellness, with antioxidant and anti-inflammatory properties that support a healthy immune system and healthy skin; also important for testosterone production and wound healing. Sold as office-use supply to licensed healthcare providers.
- Methylcobalamin Injection Active form of vitamin B12 (5mg/mL) injection for IV/IM/SQ administration. Supports energy production, metabolism, blood cell formation, and nerve function. Used to address vitamin B12 deficiencies and commonly incorporated in energy-level support regimens. Sold as office-use supply to licensed healthcare providers.
- Glutathione Injections Antioxidant formulation (200mg/mL) for IV, IM, or SQ administration. A naturally occurring tripeptide made from cysteine, glutamic acid, and glycine that neutralizes free radicals, supports detoxification pathways, and promotes healthy immune function. Supports cellular health, vitality, and overall wellness. Sold as office-use supply to licensed healthcare providers.
- Magnesium Chloride Highly bioavailable magnesium injection (300mg/mL) for IV administration. Essential mineral important for nervous, skeletal, and muscular system function. Helps regulate cellular calcium levels, promoting heart health and bone strength; used for stress reduction, anxiety management, and sleep support. Sold as office-use supply to licensed healthcare providers.
- Vita Complex Injection Comprehensive B-complex vitamin blend in a 30mL vial containing Thiamine HCl (B1), Niacinamide (B3), Riboflavin 5 Phosphate (B2), Dexpanthenol (B5), and Pyridoxine HCl (B6). Supports energy metabolism, food-to-energy conversion, and healthy skin through moisture retention and barrier function. For IV/IM/SQ administration. Sold as office-use supply to licensed healthcare providers.
- Taurine Injection Amino acid injection (50mg/mL) for IV/IM/SQ administration. Supports cardiovascular health, liver function, metabolic processes, cognitive health, nerve cell protection, memory, mood, and heart health through impact on excitatory nerve signals and cholesterol metabolism. Sold as office-use supply to licensed healthcare providers.
Quantifiable outcome
- State-licensed in 29 states with expansion planned throughout 2026
- +1 more outcomes
Companies that use Wesley Pharmaceuticals
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Wesley Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Wesley Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Olympia PharmaceuticalscoreOlympia Pharmaceuticals founded Wesley Pharmaceuticals as a sister company. Wesley serves as a 503B outsourcing facility while Olympia operates as a 503A pharmacy. Both companies share a unified ordering portal for healthcare providers. Products sourced from Olympia's existing portfolio are now available through Wesley's nationwide client network, expanding the wellness ecosystem offerings.
Scale indicators4 records
Recent moves9 records
Expansion highlights5 records
Wesley Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- QuVa Pharma: QuVa Pharma is one of the largest FDA-registered 503B outsourcing facilities in the US, producing sterile injectable compounded medications for hospital and clinic office use. It is the most direct peer to Wesley in terms of regulatory model, customer base (healthcare providers), and product category (injectable sterile compounds).
- Leiters: Leiters is an FDA-registered 503B outsourcing facility specializing in sterile injectable preparations and ophthalmic compounds supplied to hospitals and medical practices. It competes with Wesley on the same office-use injectable channel with overlapping product types such as vitamins, minerals, and sterile compounds.
- Fagron: Fagron is a global leader in pharmaceutical compounding, operating both 503A and 503B models and supplying compounded preparations, APIs, and sterile injectables to pharmacies and healthcare providers. Its 503B US operations directly overlap with Wesley's sterile injectable outsourcing model.
- Empower Pharmacy: Empower Pharmacy is a large 503A/503B compounding pharmacy offering sterile injectables, hormone therapy, and wellness products to providers and patients nationwide. It competes with Wesley across both the office-use injectable channel and the wellness/longevity injectable segment.
- Long Grove Pharmaceuticals (formerly SCA Pharmaceuticals): Long Grove Pharmaceuticals operates an FDA-registered 503B outsourcing facility producing sterile injectable preparations for hospital systems and clinics. It is comparable to Wesley in regulatory classification, sterile injectable focus, and B2B healthcare provider distribution.
- Premier Pharmacy Labs: Premier Pharmacy Labs is a 503B outsourcing facility producing sterile injectable medications for hospital and clinic office use, with a focus on batch-prepared compounds. Its sterile injectable offering, customer base, and 503B business model closely mirror Wesley's go-to-market.
- Wells Pharmacy Network: Wells Pharmacy Network operates an FDA-registered 503B outsourcing facility specializing in sterile and non-sterile compounded preparations for healthcare providers. It competes with Wesley in the same office-use supply channel across injectable and topical formulations.
- Edge Pharma: Edge Pharma is an FDA-registered 503B outsourcing facility producing sterile injectable compounded medications including allergy, hormone, and wellness injectables. Its product mix and provider-customer focus overlap significantly with Wesley's wellness injectable portfolio.
Others
- Olympia Pharmaceuticals: Olympia Pharmaceuticals is Wesley's parent and sister company, operating a 503A compounding pharmacy serving patient-specific prescriptions. While not a direct competitor, the two are operationally linked through a shared unified ordering portal and product sourcing pipeline, making Olympia the most strategically relevant counterparty.
- PCCA (Professional Compounding Centers of America): PCCA is a compounding-focused supplier of APIs, bases, equipment, and training to compounding pharmacies and 503B outsourcing facilities. It is an ecosystem enabler rather than a direct competitor but is materially relevant to Wesley's supply chain and formulary development.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wesley Pharmaceuticals social profiles
Digital presenceWesley Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wesley Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles9 records
Wesley Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wesley Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wesley Pharmaceuticals
What does Wesley Pharmaceuticals do?
Wesley Pharmaceuticals is an FDA-registered 503B outsourcing facility that manufactures and supplies cGMP-compliant sterile compounded injectable medications directly to licensed healthcare providers and pharmacies for office administration. The company produces wellness, longevity, immune support, and metabolic health injections including NAD+, Zinc Sulfate, Methylcobalamin, Glutathione, Magnesium Chloride, Vita Complex, and Taurine formulations, packaged in modernized vials with flip-top caps and durable glass construction.
Is Wesley Pharmaceuticals a public or private company?
Wesley Pharmaceuticals is a private company. It is classified as family owned and is currently operating.
When was Wesley Pharmaceuticals founded?
Wesley Pharmaceuticals was founded in 2025. It employs 11 to 50 people.
Where is Wesley Pharmaceuticals based?
Wesley Pharmaceuticals is headquartered in Orlando, United States, in the North America region.
How does Wesley Pharmaceuticals make money?
Two revenue lines are on record. Office-Use Pharmaceutical Sales are the primary driver. The others are over-the-Counter Pharmacy Stock.
Who are Wesley Pharmaceuticals's main competitors?
Direct peers on record are QuVa Pharma, Leiters, Fagron, Empower Pharmacy, Long Grove Pharmaceuticals (formerly SCA Pharmaceuticals), Premier Pharmacy Labs, Wells Pharmacy Network and Edge Pharma. Others are Olympia Pharmaceuticals and PCCA (Professional Compounding Centers of America).
Does Wesley Pharmaceuticals have an API?
No public API is recorded for Wesley Pharmaceuticals.
What industry is Wesley Pharmaceuticals in?
Wesley Pharmaceuticals's product category is Compounded Pharmaceuticals. Its primary akta.pro industry code is HLAIACAO, Specialty Injectable & Infusion Therapies (Cross-therapeutic), with a secondary code of HSABALAL, Compounding & Customized Medication Management Support. Its NAICS code is 325412 and its SIC code is 2834.